-
Medical advances in recent decades have resulted in an increased frequency of invasive fungal infections. Specific patient-groups, such as the immunocompromised patients, are especially susceptible to fungal pathogens.
-
-
Most physicians are aware that Roche withheld the distribution and sales of Tamiflu several weeks ago in order to prevent indiscriminate stock piling of drug badly needed for patients with Influenza A and B this coming winter.
-
Treatments for Acute Migraine; Statin Therapy for ACS Patients; The Correct Dosing for Onychomycosis; FDA Actions
-
The most recent HIV data show that about 1 million Americans are living with HIV, and the epidemic is becoming more firmly entrenched in the African American community, who now account for 47% of people estimated to be living with HIV.
-
Name-based reporting of HIV infection has been successful in New York City since it was begun in June 2000, but holes still remain in the surveillance system in which thousands of HIV-infected individuals are lost, according to recent research.
-
The FDA issued an approval on May 31 for a generic formulation of foscarnet sodium injection, 24 mg/mL, 250 mL, and 500 mL single-dose containers, manufactured by Pharmaforce Inc. of Columbus, OH.
-
The Diffusion of Effective Behavioral Interventions (DEBI) list of HIV prevention programs that are evidence-based was compiled by the CDC for the purpose of giving states and community organizations detailed models for providing prevention services.
-
The use of crystal methamphetamines doubles a persons risk for HIV infections, and there has been increasing awareness among public health officials that methamphetamine use is driving new HIV infections, especially among men who have sex with men (MSM), an expert says.
-
While surveying long-term data of HIV-infected people, an investigator was struck by how commonly HIV patients were diagnosed with depression.
